Radionuclide tracers in the evaluation of resting myocardial ischaemia and viability

Of all the tracer techniques currently available for the detection of myocardial viability, it is the classic pattern of fluorine-18 deoxyglucose-perfusion mismatch that is clearest from the conceptual point of view and consistently gives good predictive values. Measurements of absolute rates of glucose uptake depend on the much criticized lumped constant, never validated for myocardial ischaemia, and may provide little additional information or may even be confusing because of the bi-directional changes in glucose uptake in response to increasing ischaernia. Labelled nitroimidazole compounds are currently of interest because they are “ischaemiaavid” and because they can be imaged by a gamma camera. Nevertheless, much more work is required to show whether retention of nitroimidazole in ischaemic tissue may reflect viability.

[1]  R. Bolli,et al.  Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow. , 1996, Journal of molecular and cellular cardiology.

[2]  S L Bacharach,et al.  Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. , 1991, Circulation.

[3]  Y. Yonekura,et al.  Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  S. Rahimtoola,et al.  The hibernating myocardium. , 1989, American heart journal.

[5]  M. Phelps,et al.  Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. , 1995, Circulation.

[6]  E. Fallen,et al.  Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose? , 1997, Journal of the American College of Cardiology.

[7]  Y. Yonekura,et al.  Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. , 1989, The American journal of cardiology.

[8]  U. Ruotsalainen,et al.  Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans. , 1994, The American journal of physiology.

[9]  B. Gerber,et al.  Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting. , 1997, The Journal of thoracic and cardiovascular surgery.

[10]  H. Schelbert,et al.  Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. , 1996, Circulation.

[11]  A. Nunn,et al.  Nitroimidazoles for imaging hypoxic myocardium , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[12]  D. Miller The growing flood of technetium-99m myocardial perfusion agents. More water ... or more mud? , 1995, Circulation.

[13]  M P Sandler,et al.  Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  R O Bonow,et al.  Identification of viable myocardium. , 1996, Circulation.

[15]  C. Stone,et al.  Acute myocardial ischemia causes a transmural gradient in glucose extraction but not glucose uptake. , 1992, The American journal of physiology.

[16]  L. Opie,et al.  Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. , 1989, Progress in cardiovascular diseases.

[17]  M. Schwaiger,et al.  The relationship between myocardial blood flow and glucose uptake in ischemic canine myocardium determined with fluorine-18-deoxyglucose. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  M Schwaiger,et al.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.

[19]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[20]  A Bol,et al.  Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. , 1996, Circulation.

[21]  J J Bax,et al.  Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. , 1996, Journal of the American College of Cardiology.

[22]  Y. Yonekura,et al.  Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction , 1996, European Journal of Nuclear Medicine.

[23]  J. Balschi,et al.  1H NMR spectroscopic imaging of myocardial triglycerides in excised dog hearts subjected to 24 hours of coronary occlusion. , 1996, Circulation.

[24]  A. Arai,et al.  Metabolic adaptation to a gradual reduction in myocardial blood flow. , 1995, Circulation.

[25]  R. Sh A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. , 1985, Circulation.

[26]  H. Nick,et al.  Regulation of annexin I in adipogenesis: cAMP-independent action of methylisobutylxanthine. , 1992, The American journal of physiology.

[27]  G. Johnson,et al.  99mTc-HL91. Effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent. , 1997, Circulation.

[28]  M. Schwaiger,et al.  Myocardial Glucose Uptake in Patients With Insulin‐Dependent Diabetes Mellitus Assessed Quantitatively by Dynamic Positron Emission Tomography , 1993, Circulation.

[29]  H. Taegtmeyer,et al.  Fundamental limitations of [18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. , 1995, Circulation.

[30]  S. Vatner,et al.  Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning? , 1995, Circulation research.

[31]  S. Rahimtoola Hibernating myocardium has reduced blood flow at rest that increases with low-dose dobutamine. , 1996, Circulation.

[32]  P. Nuutila,et al.  The effect of insulin and FFA on myocardial glucose uptake. , 1995, Journal of molecular and cellular cardiology.

[33]  A. Bol,et al.  Mechanisms of Chronic Regional Postischemic Dysfunction in Humans New Insights From the Study of Noninfarcted Collateral‐Dependent Myocardium , 1993, Circulation.

[34]  K. Krohn,et al.  Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  L. Opie,et al.  Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. , 1990, Circulation research.

[36]  G. Radda,et al.  The role of Na+/K+ ATPase activity during low flow ischemia in preventing myocardial injury: A 31P, 23Na and 87Rb NMR spectroscopic study , 1995, Magnetic resonance in medicine.

[37]  J. Flack,et al.  Benefits of adherence to anti-hypertensive drug therapy. , 1996, European heart journal.

[38]  H. Schelbert,et al.  Myocardial viability: methods of assessment and clinical relevance. , 1996, American heart journal.

[39]  J. Canty,et al.  18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium. , 1997, Circulation.

[40]  L. Opie,et al.  Coronary flow and glucose delivery as determinants of contracture in the ischemic myocardium. , 1995, Journal of molecular and cellular cardiology.

[41]  J. Kronauge,et al.  Divergent Kinetics of 201TI and 99mTc‐SESTAI4IBI in Cultured Chick Ventricular Myocytes During ATP Depletion , 1992, Circulation.

[42]  P. McLaughlin,et al.  Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? , 1990, Circulation.

[43]  J. Vanoverschelde,et al.  Chronic myocardial hibernation in humans. From bedside to bench. , 1997, Circulation.

[44]  R. Gropler,et al.  Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. , 1993, Journal of the American College of Cardiology.

[45]  L. Opie Reperfusion injury and its pharmacologic modification. , 1989, Circulation.

[46]  L. Opie Metabolism of the heart in health and disease. Part I , 1968 .

[47]  R. Brunken,et al.  Present assessment of myocardial viability by nuclear imaging. , 1996, Seminars in nuclear medicine.

[48]  S. Rahimtoola A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. , 1985, Circulation.

[49]  G. Diamond,et al.  Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. , 1978, American heart journal.

[50]  J. Ferguson,et al.  Meeting Highlights American College of Cardiology 45th Annual Scientific Session, Orlando, Florida, March 24 to 27, 1996 , 1996 .

[51]  R. Bonow Identification of viable myocardium in patients with coronary artery disease and left ventricular dysfunction , 1993 .

[52]  P. Camici,et al.  Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. , 1996, Circulation.

[53]  D. Hearse Stunning: A radical re-view , 1991, Cardiovascular Drugs and Therapy.

[54]  D. Miller,et al.  Fatty acid analogue accumulation: a marker of myocyte viability in ischemic-reperfused myocardium. , 1988, Circulation research.

[55]  H. Schelbert Different roads to the assessment of myocardial viability. Lessons from PET for SPECT. , 1995, Circulation.

[56]  D. Hearse Myocardial ischaemia: can we agree on a definition for the 21st century? , 1994, Cardiovascular research.

[57]  BharatiShivalkar,et al.  Only Hibernating Myocardium Invariably Shows Early Recovery After Coronary Revascularization , 1996 .

[58]  H. Iida,et al.  Glucose uptake in the chronically dysfunctional but viable myocardium. , 1996, Circulation.